sb 216763 has been researched along with Neuroblastoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duffy, DJ; Higgins, DG; Kolch, W; Krstic, A; Schwarzl, T | 1 |
| Acevedo, KM; Bush, AI; Camakaris, J; Challis, LM; Li, QX; Norrish, D; Opazo, CM; White, AR | 1 |
| Carlyle, BC; Christie, S; Mackie, S; Millar, JK; Porteous, DJ | 1 |
| Duan, XW; Shen, JY; Wang, HJ; Xiong, NX; Yi, XX; Zhao, HY | 1 |
| Satayavivad, J; Thiantanawat, A; Watcharasit, P | 1 |
5 other study(ies) available for sb 216763 and Neuroblastoma
| Article | Year |
|---|---|
GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling.
Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Humans; Indoles; Lithium Chloride; Maleimides; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Oximes; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA Stability; RNA, Messenger; Time Factors; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2014 |
Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells.
Topics: Adjuvants, Immunologic; Aminophenols; Amyloid beta-Protein Precursor; Animals; Axons; Cell Line, Tumor; Copper; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Indoles; Lithium Chloride; Maleimides; Mice; Mutation, Missense; Neuroblastoma; Phosphorylation; Protein Transport; Synapses | 2014 |
Co-ordinated action of DISC1, PDE4B and GSK3β in modulation of cAMP signalling.
Topics: Cell Line, Tumor; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Lithium Chloride; Maleimides; Nerve Tissue Proteins; Neuroblastoma; Signal Transduction; Transfection | 2011 |
GSK-3β activation mediates Nogo-66-induced inhibition of neurite outgrowth in N2a cells.
Topics: Animals; Cell Line, Tumor; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; GPI-Linked Proteins; Indoles; Maleimides; Mice; Myelin Proteins; Nerve Regeneration; Neural Inhibition; Neurites; Neuroblastoma; Neurogenesis; Nogo Receptor 1; Phosphorylation; Receptors, Cell Surface; RNA Interference; RNA, Small Interfering | 2011 |
GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption.
Topics: Apoptosis; Arsenites; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Activation; Glycogen Synthase Kinase 3; Humans; Indoles; Lithium Compounds; Maleimides; Mitochondria; Neuroblastoma; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Signal Transduction; Sodium Compounds; Tumor Suppressor Protein p53 | 2008 |